Skip to content
ph_le_brun_pict

Seminar Title

 

Synergy Interactive Session: Ready to use Drugs – a useful option for patient safety (supported by an educational grant from Roche)

Affiliation

Central Hospital Pharmacy of The Hague

Country

The Netherlands

1. Current Status, Position

Dr. Le Brun (Pharm D) is head of production of the Central Hospital Pharmacy of The Hague and assistant professor GMP at the Leiden University Hospital, in Leiden, The Netherlands.

2. Education

Dr. Paul PH Le Brun obtained his degree in pharmacy from the Groningen University in 1982. He started his career at the Dutch Laboratory of Pharmacists (LNA), department of the Royal Dutch Association of Pharmacists. From 1985 to 1988, he trained and worked as a hospital pharmacist in the Central Hospital Pharmacy of The Hague (AHZ). He joined Merck Sharp&Dohme as production pharmacist from 1989 to 1992. In 1992 he was appointed head of production of the Central Hospital Pharmacy of The Hague, where to date he still works. From 2007 until 2012 he was a member of the board of the Dutch Society of Hospital Pharmacists (NVZA). To date he is member of the board of the Dutch affiliate of the International Society of Pharmaceutical Engineering (ISPE-NL). He is also member of the EDQM Reconstitution working party to prepare a guidance document “Reconstitution of medicinal products in healthcare establishments”.

3. Research Area

In 2001, he obtained his Ph.D on the improvement and development of antibiotic inhalation for CF patients. The title of his thesis reads: “Optimization of antibiotic inhalation therapy in Cystic Fibrosis. He has conducted studies on nebulized tobramycin. He has wokred on the development of colistin dry powder inhaler system”. He further specialized as clinical pharmacologist in 2002. Paul is one of the editors of “Practical Pharmaceutics” 2015, a standard textbook on pharmacy products and preparations.

4. Conflict of interest: none

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.